EQS-News: After a mixed 2023 financial year, aap makes a strong start to the 2024 financial year
After a mixed 2023 financial year, aap makes a strong start to the 2024 financial year
- After a mixed 2023 financial year, aap makes a strong start to the 2024 financial year
The issuer is solely responsible for the content of this announcement. - In the past financial year, aap Implantate AG ("aap" or "Company") was able to significantly accelerate patient recruitment with the realignment of the world's first clinical human study for its innovative antibacterial implant technology.
- Building on these promising developments, aap will continue its efforts to attract significant third-party funding for the industrial expansion of the technology in the 2024 financial year.
- After a mixed 2023 financial year in the LOQTEQ® trauma division, aap was able to make a positive start to the new 2024 financial year.